View PDF ↗
PDF Viewer
Open Full PDF

BUILDER'S SANDBOX

Build This Paper

Use an AI coding agent to implement this research.

OpenAI Codex
OpenAI CodexAI Agent

Lightweight coding agent in your terminal.

Claude Code
Claude CodeAI Agent

Agentic coding tool for terminal workflows.

AntiGravity IDE
AntiGravity IDEScaffolding

AI agent mindset installer and workflow scaffolder.

Cursor
CursorIDE

AI-first code editor built on VS Code.

VS Code
VS CodeIDE

Free, open-source editor by Microsoft.

MVP Investment

$10K - $13K
6-10 weeks
Engineering
$8,000
Cloud Hosting
$240
SaaS Stack
$800
Domain & Legal
$500

6mo ROI

2-4x

3yr ROI

10-20x

Lightweight AI tools can reach profitability quickly. At $500/mo average contract, 20 customers = $10K MRR by 6mo, 200+ by 3yr.

Talent Scout

F

Fatemeh Khalvandi

Razi University

S

Saadat Izadi

Razi University

A

Abdolah Chalechale

Razi University

Find Similar Experts

Healthcare experts on LinkedIn & GitHub

References (39)

[1]
ADAMAEX—Alzheimer’s disease classification via attention-enhanced autoencoders and XAI
2025Doorgeshwaree Bootun, Muzzammil Muhammad Auzine et al.
[2]
Federated Explainable AI-Based Alzheimer’s Disease Prediction With Multimodal Data
2025Sobhana Jahan, Md. Rawnak Saif Adib et al.
[3]
Predicting conversion of Alzheimer’s disease based on multi-modal fusion of neuroimaging and genetic data
2024Yang Xi, Qian Wang et al.
[4]
Unveiling the decision making process in Alzheimer’s disease diagnosis: A case-based counterfactual methodology for explainable deep learning
2024Adarsh Valoor, G. R. Gangadharan
[5]
Multimodal mixing convolutional neural network and transformer for Alzheimer's disease recognition
2024Junde Chen, Yun Wang et al.
[6]
A feature-aware multimodal framework with auto-fusion for Alzheimer's disease diagnosis
2024Meiwei Zhang, Qiushi Cui et al.
[7]
A novel interactive deep cascade spectral graph convolutional network with multi-relational graphs for disease prediction
2024Si-Hui Li, Rui Zhang
[8]
Predicting long-term progression of Alzheimer’s disease using a multimodal deep learning model incorporating interaction effects
2024Yifan Wang, Ruitian Gao et al.
[9]
Multimodal classification of Alzheimer's disease and mild cognitive impairment using custom MKSCDDL kernel over CNN with transparent decision-making for explainable diagnosis
2024V. Adarsh, G. R. Gangadharan et al.
[10]
Alzheimer's disease prediction algorithm based on de-correlation constraint and multi-modal feature interaction
2024Jiayuan Cheng, Huabin Wang et al.
[11]
A Graph Convolutional Network Based on Univariate Neurodegeneration Biomarker for Alzheimer’s Disease Diagnosis
2023Z. Qu, T. Yao et al.
[12]
Demystifying Oversmoothing in Attention-Based Graph Neural Networks
2023Xinyi Wu, A. Ajorlou et al.
[13]
A Survey on Oversmoothing in Graph Neural Networks
2023T. Konstantin Rusch, Michael M. Bronstein et al.
[14]
Multi-model adaptive fusion-based graph network for Alzheimer's disease prediction
2023Fusheng Yang, Hua-bin Wang et al.
[15]
Explainable Artificial Intelligence of Multi-Level Stacking Ensemble for Detection of Alzheimer’s Disease Based on Particle Swarm Optimization and the Sub-Scores of Cognitive Biomarkers
2023Abdulaziz Almohimeed, Redhwan M. A. Saad et al.
[16]
Deep Multi-Modal Discriminative and Interpretability Network for Alzheimer’s Disease Diagnosis
2022Qi Zhu, Bingliang Xu et al.
[17]
Cascaded Multi-Modal Mixing Transformers for Alzheimer’s Disease Classification with Incomplete Data
2022Linfeng Liu, Siyu Liu et al.
[18]
An Attention-Based 3D CNN With Multi-Scale Integration Block for Alzheimer's Disease Classification
2022Yuanchen Wu, Yuan Zhou et al.
[19]
Unsupervised pre-training of graph transformers on patient population graphs
2022Chantal Pellegrini, N. Navab et al.
[20]
CNNG: A Convolutional Neural Networks With Gated Recurrent Units for Autism Spectrum Disorder Classification
2022Wenjing Jiang, Shuaiqi Liu et al.

Showing 20 of 39 references

Founder's Pitch

"Develop an AI-driven tool for interpretable Alzheimer’s disease diagnosis using multimodal data."

Healthcare AIScore: 7View PDF ↗

Commercial Viability Breakdown

0-10 scale

High Potential

1/4 signals

2.5

Quick Build

4/4 signals

10

Series A Potential

2/4 signals

5

Sources used for this analysis

arXiv Paper

Full-text PDF analysis of the research paper

GitHub Repository

Code availability, stars, and contributor activity

Citation Network

Semantic Scholar citations and co-citation patterns

Community Predictions

Crowd-sourced unicorn probability assessments

Analysis model: GPT-4o · Last scored: 2/17/2026

🔭 Research Neighborhood

Generating constellation...

~3-8 seconds

Why It Matters

Accurate and early diagnosis of Alzheimer's disease is critical for effective treatment and management but remains challenging with traditional methods. This research proposes a novel method that significantly improves diagnostic accuracy, leveraging advanced graph-based learning models.

Product Angle

To productize, develop a cloud-based API service that hospitals can integrate into their diagnostic systems, allowing real-time processing of patient data to deliver interpretable Alzheimer's risk assessments.

Disruption

This approach can replace traditional diagnosis methods, which often rely on costly and less accurate imaging or clinical evaluations, offering a more comprehensive and interpretable alternative.

Product Opportunity

As the elderly population grows, the demand for reliable Alzheimer's diagnostics increases. Healthcare providers are potential customers for a tool that can enhance diagnostic accuracy and reduce clinical assessment time.

Use Case Idea

Create a clinical decision support tool for hospitals to interpretably diagnose Alzheimer's disease using patient cognitive, MRI, and risk factor data.

Science

The study presents a Meta-Relational Copula-Based Graph Attention Network (MRC-GAT). It uses a copula-based alignment to handle multimodal data, integrating features such as cognitive scores and MRI data. The model applies relational attention mechanisms and node-wise fusion for learning, achieving state-of-the-art accuracy in Alzheimer's diagnosis.

Method & Eval

The method was evaluated using TADPOLE and NACC datasets, showing accuracies of 96.87% and 92.31% respectively, thus outperforming existing diagnostic models.

Caveats

The model may face challenges generalizing beyond the studied datasets and handling smaller datasets. Complex interpretability might not be straightforward for clinical use without additional validation studies.

Author Intelligence

Fatemeh Khalvandi

Razi University
f.khalvandi@stu.razi.ac.ir

Saadat Izadi

Razi University
s.izadi@razi.ac.ir

Abdolah Chalechale

Razi University
chalechale@razi.ac.ir